These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 21769421

  • 21. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D, Ribeiro JA, Sebastião AM.
    Brain Res; 2005 Jul 05; 1049(1):52-60. PubMed ID: 15935995
    [Abstract] [Full Text] [Related]

  • 22. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation.
    Palus K, Całka J, Jana B.
    Anim Reprod Sci; 2021 Feb 05; 225():106680. PubMed ID: 33388613
    [Abstract] [Full Text] [Related]

  • 23. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T.
    J Neuroimmunol; 2005 Jan 05; 158(1-2):94-105. PubMed ID: 15589042
    [Abstract] [Full Text] [Related]

  • 24. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
    J Cell Physiol; 2009 Oct 05; 221(1):75-83. PubMed ID: 19496170
    [Abstract] [Full Text] [Related]

  • 25. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
    Fung C, Unterweger P, Parry LJ, Bornstein JC, Foong JP.
    Am J Physiol Gastrointest Liver Physiol; 2014 May 01; 306(9):G748-58. PubMed ID: 24578344
    [Abstract] [Full Text] [Related]

  • 26. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 01; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 27. Activation of the VIP/VPAC2 system induces reactive astrocytosis associated with increased expression of glutamate transporters.
    Nishimoto M, Miyakawa H, Wada K, Furuta A.
    Brain Res; 2011 Apr 06; 1383():43-53. PubMed ID: 21281617
    [Abstract] [Full Text] [Related]

  • 28. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M, Robledo G, Rueda B, Varela N, O'Valle F, Hernandez-Cortes P, Caro M, Orozco G, Gonzalez-Rey E, Martin J.
    Arthritis Rheum; 2008 Apr 06; 58(4):1010-9. PubMed ID: 18383379
    [Abstract] [Full Text] [Related]

  • 29. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B.
    J Comp Neurol; 2006 Jun 01; 496(4):468-78. PubMed ID: 16572459
    [Abstract] [Full Text] [Related]

  • 30. Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes.
    Lara-Marquez ML, O'Dorisio MS, Karacay B.
    Ann N Y Acad Sci; 2000 Jun 01; 921():45-54. PubMed ID: 11193874
    [Abstract] [Full Text] [Related]

  • 31. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.
    Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B.
    J Immunol; 2001 Feb 15; 166(4):2522-30. PubMed ID: 11160313
    [Abstract] [Full Text] [Related]

  • 32. Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.
    Vomhof-DeKrey EE, Sandy AR, Failing JJ, Hermann RJ, Hoselton SA, Schuh JM, Weldon AJ, Payne KJ, Dorsam GP.
    Peptides; 2011 Oct 15; 32(10):2058-66. PubMed ID: 21878358
    [Abstract] [Full Text] [Related]

  • 33. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
    Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI.
    J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712
    [Abstract] [Full Text] [Related]

  • 34. Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line.
    Pan CQ, Hamren S, Roczniak S, Tom I, DeRome M.
    Peptides; 2008 Mar 30; 29(3):479-86. PubMed ID: 17942192
    [Abstract] [Full Text] [Related]

  • 35. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
    Li GH, Qian W, Song GQ, Hou XH.
    J Gastroenterol Hepatol; 2007 Aug 30; 22(8):1328-35. PubMed ID: 17559364
    [Abstract] [Full Text] [Related]

  • 36. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.
    Couvineau A, Maoret JJ, Rouyer-Fessard C, Carrero I, Laburthe M.
    Biochem J; 2000 May 01; 347 Pt 3(Pt 3):623-32. PubMed ID: 10769164
    [Abstract] [Full Text] [Related]

  • 37. Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor.
    Voice JK, Dorsam G, Lee H, Kong Y, Goetzl EJ.
    FASEB J; 2001 Nov 01; 15(13):2489-96. PubMed ID: 11689474
    [Abstract] [Full Text] [Related]

  • 38. Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog.
    Collado B, Carmena MJ, Sánchez-Chapado M, Ruíz-Villaespesa A, Bajo AM, Fernández-Martínez AB, Varga JL, Schally AV, Prieto JC.
    Int J Oncol; 2005 Jun 01; 26(6):1629-35. PubMed ID: 15870879
    [Abstract] [Full Text] [Related]

  • 39. Expression and function of genes encoding cholinergic components in murine immune cells.
    Kawashima K, Yoshikawa K, Fujii YX, Moriwaki Y, Misawa H.
    Life Sci; 2007 May 30; 80(24-25):2314-9. PubMed ID: 17383684
    [Abstract] [Full Text] [Related]

  • 40. VIP impairs acquisition of the macrophage proinflammatory polarization profile.
    Carrión M, Pérez-García S, Martínez C, Juarranz Y, Estrada-Capetillo L, Puig-Kröger A, Gomariz RP, Gutiérrez-Cañas I.
    J Leukoc Biol; 2016 Dec 30; 100(6):1385-1393. PubMed ID: 27381006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.